Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors

Detalles Bibliográficos
Autores principales: Yang, Dafu, Li, Dan, Dai, Zhaoxia, Ma, Yutong, Ou, Qiuxiang, Wu, Xue, Cui, Saiqiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896746/
https://www.ncbi.nlm.nih.gov/pubmed/33434380
http://dx.doi.org/10.1002/cac2.12128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896746/
https://www.ncbi.nlm.nih.gov/pubmed/33434380
http://dx.doi.org/10.1002/cac2.12128

Ejemplares similares